未來活動

 GRC connects

 

Join virtually on Monday, March 8th from 1:00pm – 3:00pm EST

In honor of International Women’s Day, the event will highlight the impact women have made to science and to GRC communities!

Please click here to register for this free event.  Help us spread the word by sharing this invitation with your colleagues.  Hope to see you there!

 
Event Description

The contributions made by women over the last century continue to impact the sciences and the GRC organization today. Join us on International Women’s Day, as we highlight the important work of women in our communities, and scientific talks on the subject of “Innovation by Biomaterials” at this GRC Connects event.  

Drs. Kristi Anseth and Chad A. Mirkin, both longstanding and valued members of the GRC community and GRC governance, will be featured as keynote speakers. In addition to their scientific talks, Dr. Anseth and Dr. Mirkin will discuss the contributions women have made to their research at this free event, open to all members of the scientific community and scientists of all career-stages.  Dr. Shana Kelley, University of Toronto, will moderate the discussion.  

Dr. Anseth, Professor of Chemistry and Biological Engineering at the University of Colorado at Boulder, recently awarded the L’Oreal-UNESCO for Women in Science Award in Life Sciences, will present a scientific talk titled “Advances in Precision Biomaterials to Direct Cell Organization and Tissue Regeneration.”

Dr. Mirkin, Professor of Chemistry and Director of the International Institute for Nanotechnology at Northwestern University, recently awarded the Kabiller Prize in Nanoscience and Nanomedicine, will present a scientific talk titled “Nanomedicine: Why Scale and Chemical Structure Make a Difference.”

Please join us for an engaging and informative presentation followed by a Q&A period with these influential scientists. We look forward to seeing you at the frontiers of science!

 

 About the Speakers

Kristi Anseth is a Professor of Chemical and Biological Engineering and Associate Faculty Director of the BioFrontiers Institute at the University of Colorado at Boulder. She currently holds the Tisone Professorship and is a Distinguished Professor. Dr. Anseth came to CU-Boulder after earning her B.S. degree from Purdue University, her Ph.D. degree from the University of Colorado, and completing post-doctoral research at MIT as an NIH fellow. Her research interests lie at the interface between biology and engineering where she designs new biomaterials for applications in drug delivery and regenerative medicine. Dr. Anseth’s research group has published over 350 peer-reviewed manuscripts, and she has trained more than 110 graduate students and postdoctoral associates. She is an elected member of the National Academy of Engineering (2009), the National Academy of Medicine (2009), the National Academy of Sciences (2013), the National Academy of Inventors (2016) and the American Academy of Arts and Sciences (2019). Most recently, she received the L’Oreal-UNESCO for Women in Science Award in the Life Sciences (2020). Dr. Anseth has served on the Board of Directors and as President of the Materials Research Society, the Board of Governors for Acta Materialia, Inc, the NIH Advisory Council for NIBIB, and as Chair of the NAE US Frontiers of Engineering meetings. 

Chad A. Mirkin is the Director of the International Institute for Nanotechnology and the George B. Rathmann Prof. of Chemistry, Chemical and Biological Engineering, Biomedical Engineering, Materials Science & Engineering, and Medicine at Northwestern University. He is a chemist and a world-renowned nanoscience expert, who is known for his discovery and development of spherical nucleic acids (SNAs) and SNA-based biodetection and therapeutic schemes, Dip-Pen Nanolithography (DPN) and related cantilever-free nanopatterning methodologies, On-Wire Lithography (OWL), and Co-Axial Lithography (COAL), and contributions to supramolecular chemistry and nanoparticle synthesis. He is the author of over 790 manuscripts and over 1,200 patent applications worldwide (over 355 issued), and he is the founder of multiple companies, including AuraSense, Exicure, TERA-print, Azul 3D and Stoicheia, which are commercializing nanotechnology applications in the life sciences, biomedicine, and advanced manufacturing. Mirkin has been recognized with over 230 national and international awards, including the Kabiller Prize in Nanoscience and Nanomedicine, Dan David Prize, and NAS Sackler Prize in Convergence Research. He was a Member of the President’s Council of Advisors on Science & Technology and is one of very few scientists to be elected to all three US National Academies. He is also a Fellow of the American Academy of Arts and Sciences and the National Academy of Inventors, among others. Mirkin has served on the Editorial Advisory Boards of over 30 scholarly journals, including J. Am. Chem. Soc., ACS Nano, and Nano Letters. At present, he is an Associate Editor of J. Am. Chem. Soc. and a Proc. Natl. Aca. Sci. Editorial Board Member, and he is the founding editor of the journal Small. Mirkin holds a B.S. from Dickinson College (1986, elected into Phi Beta Kappa) and a Ph.D. from the Penn. State Univ. (1989). He was an NSF Postdoctoral Fellow at the MIT prior to becoming a professor at Northwestern Univ. in 1991.

 About the Moderator

Shana Kelley is a University Professor at the University of Toronto and a member of the Departments of Chemistry, Biochemistry, Pharmaceutical Sciences and Biomedical Engineering. Dr. Kelley received her Ph.D. from the California Institute of Technology and was a NIH postdoctoral fellow at the Scripps Research Institute. The Kelley research group works in a variety of areas spanning biophysical/bioanalytical chemistry, chemical biology and nanotechnology, and has pioneered new methods for tracking molecular and cellular analytes with unprecedented sensitivity. Dr. Kelley’s work has been recognized with a variety of distinctions, including being named one of “Canada’s Top 40 under 40”, a NSERC E.W.R. Steacie Fellow, the 2011 Steacie Prize, and the 2016 NSERC Brockhouse Prize. She has also been recognized with the ACS Inorganic Nanoscience Award, the Pittsburgh Conference Achievement Award, an Alfred P. Sloan Research Fellowship, a Camille Dreyfus Teacher-Scholar award, a NSF CAREER Award, a Dreyfus New Faculty Award, and was also named a “Top 100 Innovator” by MIT’s Technology Review. Kelley is an inventor on over 50 patents issued worldwide. She is a founder of three molecular diagnostics companies, GeneOhm Sciences (acquired by Becton Dickinson in 2005), Xagenic Inc. (acquired by General Atomics in 2017), and Cellular Analytics. Kelley serves as a Board Director for Ontario Genomics and a Board Trustee for the Fight Against Cancer Innovation Trust (FACIT). She is an Associate Editor for ACS Sensors, and an Editorial Advisory Board Member for the Journal of the American Chemical Society and ACS Chemical Biology.

GRC Connects is an initiative of the Gordon Research Conferences that provides opportunities for GRC communities to connect and collaborate until we resume in-person meetings, furthering GRC's commitment to find new and creative ways to advance the frontiers of science. 

 

 


white background

Medlab Asia Pacific Exhibition and Congress
Dates: 8/4/2021 - 8/6/2021
Venue: IMPACT Arena, Bangkok, Thailand
 

MEDLAB Asia offers the medical technology industry a complete range of products, materials and services including high-tech solutions, components, pre-products, new materials and innovations.

MEDLAB Asia is an innovative laboratory exhibition and congress, which will provide an opportunity to learn about advances in science and their applications in laboratory medicine that will improve practice through improving patient outcomes.

A series of online and live events, giving you more tailored trade days, specialty days and targeted opportunities to showcase, present and connect. A unique opportunity to engage with the ASEAN community and make valuable contacts.

bip chi

由香港特別行政區政府、香港貿易發展局及香港設計中心合辦的「亞洲知識產權營商論壇」為世界各地知識產權業的專業人士和商家提供一個理想平台,就知識產權的最新發展互相交流。

第十屆「亞洲知識產權營商論壇」將於2020年12月3至4日舉行。今屆論壇將以「開放式創新: 轉變中推動協作」為主題,探討企業如何在變化萬千的時代中,利用開放式創新加強協作,並透過知識產權推動科技發展。此外,《環球科技峰會》更會討論環球最新的科技趨勢,透視顛覆式科技創新如何解決世界面對的危難與挑戰,為商業世界和人類生活帶來鉅大的變革。

主辦機構: 香港貿易發展局﹑香港特別行政區政府﹑香港設計中心
日期: 2020年12月3-4日 (星期四 至 星期五)
地點: 網上論壇
支持單位: 香港生物科技協會
網上登記: http://www.hktdc.com/ncs/bip2020/tc/s/fp-Onlineregistration.html

 

* 請在登記時,輸入香港生物科技協會的折扣代碼SO20081SD以享有網上門票特別價 - 港幣$200(原價港幣$550)。

聯絡我們:    電話: +852 1830 668 |郵箱: bipasia@hktdc.org | 網站: http://bipasiaforum.com/tc

YA_WB_Sub_T_202011.jpg

聞「毒」喪膽: 淺談「病毒」對人類的威脅

日期/時間: 待定
講者: 李小羿博士 (香港生物科技協會副主席、香港科技大學客席教授)
機構: 香港公共圖書館與香港生物科技協會合辦
備註: 講座以粵語進行。
查詢電話: 2921 0335
網址: https://www.hkpl.gov.hk/tc/extension-activities/event-detail/179920/fear-of-poison-introduction-to-threat-of-virus-to-humans 

 

因應疫情,是次講座將以錄影形式進行,不設現場觀眾。講座錄影稍後於香港公共圖書館多媒體資訊系統或其他平台播放,詳情將於香港公共圖書館網頁公布,敬請密切留意。

講者會在講座中深入淺出地以生物科技角度跟大家分享病毒如何對人類性命產生巨大威脅。

現代醫學知識與生物科技突飛猛進,但是人類對病毒的了解仍然很有限。人類在進步,病毒也在不斷變異更新換代;如今全球交流頻繁、城市人口密集,病毒對人類的威脅只會更頻繁、更難以防範。

是次講座內容會讓大家體會到現代生物科技及醫療技術的進步和發展,如何對病毒引起的疾病之治療以及其他嶄新醫療等領域作出貢獻。

CLSC

 【大会简介】为了发挥“2020中国精准医学大会、2020中国生命科学大会”的学术价值及影响力,响应党 中央“一带一路”倡议和“实施健康中国战略”的号召,由国家卫生健康委支持指导,中国医院协 会主办,广东标杆会展有限公司承办的2020中国精准医学大会、2020中国生命科学大会及展览 会,将于2020年12月26-28日在广州保利世贸博览馆召开。

为进一步促进我国精准医学及生命科学实现跨越式创新发展,也为展示我国科学家在精准医学 及生命科学领域的实力和创新性成果、促进多学科交叉融合、推动上下游产业间的交流合作。

本届大会将聚焦科学前沿和健康促进的热点问题,在保持生命科学前沿交流的基础上,进一步 侧重我国及发展中国家更为关注的健康促进、慢病防控和老龄化应对等热点问题。

聚焦生命科学领域前沿进展、生物技术领域风向标以及健康领域民众普遍关注的热点,开展高 水平的学术交流和最新成果展示,推动生命科学研究和技术创新取得更多突破,大会一方面将提高 会议学术交流的效率,另一方面凸显生命科学进展在人类健康共同体构建中的作用,将是世界生命 科学和中国生命科学界的一次盛会。

大会同期附设世界生命科学展,本次展览将为国内外生物技术企业及研发机构提供与世界优秀 的科研团队进行近距离交流的难得机会和展示实力、推广产品、拓展市场的良好契机。

Free Joomla! template by Age Themes